Replies to post #37731 on Medizone Intl. (fka MZEIQ)

[Zeppo]

I pointed out, several months ago, a non-invasive diagnostic test for cervical cancer that is being used in the developing world and is now being embraced in part of the developed world. A test center is being set up in Canada with none other than C3 (it's NOT approved there yet) as the potential distributor. The test has EU approval (based on the U.S. test) and is approved in Mexico and Central and South America. Why hasn't a test center for Asepticsure been set up in Canada? Canada could have been a test center powerhouse for Asepticsure over the last three years. Yet no money was spent to develop something that important to the future of the company. Canada was mentioned so little in this week's Chairman's Letter that, to someone reading it for the first time, the person would have no idea Medizone has had an approved product up there.